[ Price : $8.95]
Three groups make suggestions for FDA to consider in writing a guidance on co-developing investigational drugs.[ Price : $8.95]
FDA says it has begun a safety review of Takeda's diabetes drug Actos (pioglitazone) due to potential bladder risks.[ Price : $8.95]
Federal Register Final rule: FDA corrects a small error in a 4/14 final rule on removing essential-use designations for certain su...[ Price : $8.95]
Federal Register Notice: FDA and the Centers for Medicare and Medicaid Services seek comments on what products would be appropriat...[ Price : $8.95]
The House Oversight and Government Reform Committee asks two Johnson & Johnson executives to clarify information on the companys r...[ Price : $8.95]
CDER compliance director Deborah Autor says a worldwide alliance of drug regulators is needed because no country can keep up with ...[ Price : $8.95]
Federal Register Notice: FDAs Tobacco Products Scientific Advisory Committee will meet 10/7 on industry documents on the use of me...[ Price : $8.95]
FDA asks its Cardiovascular and Renal Drugs Advisory Committee to comment on the safety, effectiveness, and risk/benefit of Boehri...